BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 8504050)

  • 1. PUVA erythemal sensitivity depends on plasma psoralen concentration and UVA sensitivity.
    Sakuntabhai A; Farr PM; Diffey BL
    Br J Dermatol; 1993 May; 128(5):561-5. PubMed ID: 8504050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between plasma psoralen concentration and psoralen-UVA erythema.
    Mclelland J; Fisher C; Farr PM; Diffey BL; Cox NH
    Br J Dermatol; 1991 Jun; 124(6):585-90. PubMed ID: 2064944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythemal and therapeutic response of psoriasis to PUVA using high-dose UVA.
    Speight EL; Farr PM
    Br J Dermatol; 1994 Nov; 131(5):667-72. PubMed ID: 7999598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the dose-response relationship for psoralen-UVA erythema and UVB erythema.
    Cox NH; Farr PM; Diffey BL
    Arch Dermatol; 1989 Dec; 125(12):1653-7. PubMed ID: 2589859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanocortin 1 receptor (MC1R) genotype influences erythemal sensitivity to psoralen-ultraviolet A photochemotherapy.
    Smith G; Wilkie MJ; Deeni YY; Farr PM; Ferguson J; Wolf CR; Ibbotson SH
    Br J Dermatol; 2007 Dec; 157(6):1230-4. PubMed ID: 17916200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoralen-ultraviolet A-induced erythema: sensitivity correlates with the concentrations of psoralen in suction blister fluid.
    Yeo UC; Shin JH; Yang JM; Park KB; Kim MM; Bok HS; Lee ES
    Br J Dermatol; 2000 Apr; 142(4):733-9. PubMed ID: 10792224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An intraindividual comparative study of psoralen-UVA erythema induced by bath 8-methoxypsoralen and 4, 5', 8-trimethylpsoralen.
    Man I; McKinlay J; Dawe RS; Ferguson J; Ibbotson SH
    J Am Acad Dermatol; 2003 Jul; 49(1):59-64. PubMed ID: 12833009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative efficacy of 335 and 365 nm radiation in photochemotherapy of psoriasis.
    Brücke J; Tanew A; Ortel B; Hönigsmann H
    Br J Dermatol; 1991 Apr; 124(4):372-4. PubMed ID: 2025558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythema action spectrum of topical 8-methoxypsoralen-sensitized skin re-evaluated: implications for routine clinical practice.
    Al-Ismail D; Edwards C; Anstey AV
    Br J Dermatol; 2016 Jan; 174(1):131-5. PubMed ID: 26383592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between 8-methoxypsoralen bath-water concentration and photosensitivity in bath-PUVA treatment.
    Tanew A; Kipfelsperger T; Seeber A; Radakovic-Fijan S; Hönigsmann H
    J Am Acad Dermatol; 2001 Apr; 44(4):638-42. PubMed ID: 11260539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of methoxsalen dose on ultraviolet-A-induced erythema.
    Ibbotson SH; Dawe RS; Farr PM
    J Invest Dermatol; 2001 May; 116(5):813-5. PubMed ID: 11348476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The time-course of psoralen ultraviolet A (PUVA) erythema.
    Ibbotson SH; Farr PM
    J Invest Dermatol; 1999 Sep; 113(3):346-50. PubMed ID: 10469332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione S-transferase genotype is associated with sensitivity to psoralen-ultraviolet A photochemotherapy.
    Ibbotson SH; Dawe RS; Dinkova-Kostova AT; Weidlich S; Farr PM; Ferguson J; Wolf CR; Smith G
    Br J Dermatol; 2012 Feb; 166(2):380-8. PubMed ID: 21967523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in 8-methoxypsoralen immersion time alters the erythemal response to bath PUVA.
    Azurdia RM; Dean MP; Rhodes LE
    Photodermatol Photoimmunol Photomed; 2000 Aug; 16(4):186-8. PubMed ID: 11019945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An intraindividual study of the characteristics of erythema induced by bath and oral methoxsalen photochemotherapy and narrowband ultraviolet B.
    Man I; Dawe RS; Ferguson J; Ibbotson SH
    Photochem Photobiol; 2003 Jul; 78(1):55-60. PubMed ID: 12929749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A reappraisal of the use of 5-methoxypsoralen in the therapy of psoriasis.
    Calzavara-Pinton P; Ortel B; Carlino A; Honigsmann H; De Panfilis G
    Exp Dermatol; 1992 Jul; 1(1):46-51. PubMed ID: 1344660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved prediction of the minimal phototoxic dose in PUVA therapy.
    Sakuntabhai A; Matthews JN; Farr PM
    Br J Dermatol; 1994 May; 130(5):604-9. PubMed ID: 8204468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large increments in psoralen-ultraviolet A (PUVA) therapy are unsuitable for fair-skinned individuals with psoriasis.
    Kirby B; Buckley DA; Rogers S
    Br J Dermatol; 1999 Apr; 140(4):661-6. PubMed ID: 10233317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of psoriasis to twice weekly PUVA.
    Sakuntabhai A; Sharpe GR; Farr PM
    Br J Dermatol; 1993 Feb; 128(2):166-71. PubMed ID: 8457450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsoriatic, erythematogenic, and Langerhans cell marker depleting effect of bath-psoralens plus ultraviolet A treatment. Comparison of 8-methoxypsoralen and trimethylpsoralen photosensitization.
    Koulu LM; Jansén CT
    J Am Acad Dermatol; 1988 May; 18(5 Pt 1):1053-9. PubMed ID: 2968374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.